PBK and non-small cell lung carcinoma: As shown in Figure 1C, Kaplan–Meier survival analysis suggested that a high level of TOPK was associated with a poorer 5‐year overall survival (OS) in NSCLC patients, which was consistent with the previous reports about the impaired survival in NSCLC patients with KRASG12C mutation.22, 23